Optimizing Treatment Expectations in Internet-based Interventions for Depressio
Not Applicable
- Conditions
- Depressive Disorders
- Registration Number
- DRKS00032982
- Lead Sponsor
- Freie Universität Berlin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Self-reported primary depression defined as reaching a cut-off of >14 on the BDI-II (Kuehner et al., 2023)
- except for benzodiazepines, concordant medication is allowed if kept constant for the four weeks before and until the end of this trial
- fluency in German language
- Internet access
- informed consent
Exclusion Criteria
- suicidality (>1 on the BDI-II suicidal ideation item)
- currently in psychotherapy
- benzodiazepine intake
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression (BDI-II): Mid- and Post-Treatment
- Secondary Outcome Measures
Name Time Method Secondary Outcomes (Baseline, Mid- and Post-Treatment):<br>-Anxiety and Depression State and Trait (STADI)<br>-Behavioral Approach System Sensitivity (BAS Subscale of the BIS/BAS)<br>-Personality (BFI-10)<br>-Disability (PDI)<br>-Negative Effects (GASE)<br>-Subjective Stress (PSS-10)<br>-Satisfaction with Treatment (CSQ-8)<br>-Adherence (Quantity;no. of modules)<br>-Adherence (Quality; self-drafted)<br><br>Change Mechanisms (weekly)<br>-Outcome Expectations (GEEE; TEX)<br>-Self-Efficacy (ASKU)<br>-Working Alliance (WAI-SR-I)<br>-Warmth and Competence of Personal Contact (self-drafted; only following personal contact)